Sevasemten 12.5 mg clinical trials

Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

This study is testing a new medicine called sevasemten (also known as EDG-5506) for adults with Becker muscular dystrophy. It wants to see if the medicine is safe and if it helps people. Early parts of the study are now full, but one large part, GRAND CANYON, has also finished taking new participants.